SAA1 and COVID-19: Comparing SAA levels with other diseases, Bhatraju et al. (2021) performed a cohort study with a sample size of 171 ICU patients aiming to compare plasma biomarkers in sepsis between COVID-19 and non-COVID-19 patients.